Reverter JC - Search Results

1

[Survey of perioperative hemostasis and transfusion management in cardiac surgery: how do anesthesiologists practice?].

Basora M, Fita G, Panigua P, Litvan H, Fló A, Reverter JC. Basora M, et al. Among authors: reverter jc. Rev Esp Anestesiol Reanim. 2010 Jan;57(1):3-10. doi: 10.1016/s0034-9356(10)70156-0. Rev Esp Anestesiol Reanim. 2010. PMID: 20196517 Spanish.

2

Characteristics and performance of the external quality assessment scheme (EQAS) for haematology in Spain. Ten years of experience.

Vives-Corrons JL, Gutiérrez G, Jou JM, Reverter JC, Martínez-Brotons F, Domingo A, Iriarte JA. Vives-Corrons JL, et al. Among authors: reverter jc. Ann Ist Super Sanita. 1995;31(1):95-101. Ann Ist Super Sanita. 1995. PMID: 8546381

3

Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect.

Castillo R, Escolar G, Monteagudo J, Aznar-Salatti J, Reverter JC, Ordinas A. Castillo R, et al. Among authors: reverter jc. Transfusion. 1997 Aug;37(8):785-90. doi: 10.1046/j.1537-2995.1997.37897424399.x. Transfusion. 1997. PMID: 9280321

4

Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes.

Reverter JC. Reverter JC. J Thromb Haemost. 2006 Apr;4(4):717-20. doi: 10.1111/j.1538-7836.2006.01887.x. J Thromb Haemost. 2006. PMID: 16634734 Free article. No abstract available.

5

Infusible platelet membranes improve hemostasis in thrombocytopenic blood: experimental studies under flow conditions.

Galán AM, Bozzo J, Hernández MR, Pino M, Reverter JC, Mazzara R, Escolar G, Ordinas A. Galán AM, et al. Among authors: reverter jc. Transfusion. 2000 Sep;40(9):1074-80. doi: 10.1046/j.1537-2995.2000.40091074.x. Transfusion. 2000. PMID: 10988310

6

Concentrates containing factor IX could improve haemostasis under conditions of thrombocytopenia: studies in an in vitro model.

Galán AM, Reverter JC, Pino M, Viñas M, Bozzo J, Hernández MR, Aznar-Salatti J, Ordinas A, Escolar G. Galán AM, et al. Among authors: reverter jc. Vox Sang. 2002 Apr;82(3):113-8. doi: 10.1046/j.1423-0410.2002.00157.x. Vox Sang. 2002. PMID: 11952983

7

Fondaparinux sodium.

Reverter JC. Reverter JC. Drugs Today (Barc). 2002 Mar;38(3):185-94. doi: 10.1358/dot.2002.38.3.820126. Drugs Today (Barc). 2002. PMID: 12532174 Review.

8

No impact of factor IX Ala-10 mutations in acenocoumarol-treated southern Europeans.

Tàssies D, Monteagudo J, Maragall S, Ordinas A, Reverter JC. Tàssies D, et al. Among authors: reverter jc. Blood Coagul Fibrinolysis. 2005 Nov;16(8):563-6. doi: 10.1097/01.mbc.0000191522.32353.17. Blood Coagul Fibrinolysis. 2005. PMID: 16269929

9

[Morbidity and mortality in patients treated with oral anticoagulants].

Navarro JL, Cesar JM, Fernández MA, Fontcuberta J, Reverter JC, Gol-Freixa J. Navarro JL, et al. Among authors: reverter jc. Rev Esp Cardiol. 2007 Dec;60(12):1226-32. doi: 10.1157/13113927. Rev Esp Cardiol. 2007. PMID: 18082087 Free article. Spanish.

10

Coagulation Factor Concentrates Fail to Restore Alterations in Fibrin Formation Caused by Rivaroxaban or Dabigatran in Studies With Flowing Blood From Treated Healthy Volunteers.

Arellano-Rodrigo E, Lopez-Vilchez I, Galan AM, Molina P, Reverter JC, Carné X, Villalta J, Tassies D, Lozano M, Díaz-Ricart M, Escolar G. Arellano-Rodrigo E, et al. Among authors: reverter jc. Transfus Med Rev. 2015 Oct;29(4):242-9. doi: 10.1016/j.tmrv.2015.08.001. Epub 2015 Aug 8. Transfus Med Rev. 2015. PMID: 26364029 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters